MedTrace Logo

Spinal Mobilization With Arm Movement and Kaltenborn Mobilization in Adhesive Capsulitis

NCT07724691 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-07-24

No results posted yet for this study

Summary

To compare the effects of spinal mobilization with arm movement and Kaltenborn Mobilization on pain, range of motion, functional reaching, and disability in patients with Adhesive Capsulitis.

Conditions

  • Adhesive Capsulitis
  • Frozen Shoulder
  • Mulligan Mobilization
  • Spinal Mobilization
  • Shoulder Pain

Interventions

OTHER

Spinal Mobilization with Arm Movement

Intervention: Spinal Mobilization with Arm Movement (SMWAM) Position: Participant seated upright with neutral spine and head posture Technique: Sustained transverse glide applied to the C4 spinous process toward the side opposite the affected shoulder during active shoulder abduction Movement: Active shoulder abduction to the pain-free or maximum tolerated range, followed by return to the starting position while maintaining the glide Dosage: 10 repetitions per session Purpose: To reduce pain, improve shoulder mobility, and enhance functional movement.

OTHER

Kaltenborn Mobilization

Intervention: Kaltenborn Mobilization Technique (KMT) Pre-treatment: Moist hot pack application Techniques: Grade I glenohumeral traction, Grade III ventral glide, and Grade III caudal glide Dosage: 15 repetitions of each technique with a 30-second hold and 10-second rest between repetitions Duration: Approximately 10 minutes per session Purpose: To improve glenohumeral joint mobility, reduce pain, and increase shoulder range of motion.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Annum Manzoor, MS OMPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2026-08-01
Completion
2026-09-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07724691 on ClinicalTrials.gov